Literature DB >> 19482183

Effect of mineral trioxide aggregate on rat clonal dental pulp cells: expression of cyclooxygenase-2 mRNA and inflammation-related protein via nuclear factor kappa B signaling system.

Hajime Minamikawa1, Yoshiaki Deyama, Kouichi Nakamura, Yoshitaka Yoshimura, Masayuki Kaga, Kuniaki Suzuki, Yasutaka Yawaka.   

Abstract

INTRODUCTION: Recently, mineral trioxide aggregate (MTA) has been routinely used for endodontic treatment. It is well-known that MTA induced secondary dentin formation in pulp cavity when it was applied to dentin, whereas its cytotoxicities were unclear. The purpose of this study was to evaluate the effect of MTA on rat clonal dental pulp cells, RPC-C2A.
METHODS: This study was conducted to observe the response of RPC-C2A cells on MTA with reverse-transcriptase polymerase chain reaction, Western blot analysis, and enzyme immunoassay. Data were compared by analysis of variance. Statistical significance was established at P <.01.
RESULTS: MTA significantly caused an up-regulation of cyclooxygenase-2 (COX-2) and inducible form of nitric oxide synthase (iNOS) mRNA expression. Furthermore, MTA caused inhibitory kappa B (IkappaB) phosphorylation and translocation of nuclear factor-kappa B (NF-kappaB) subunits to nucleus. Curucumin, an inhibitor of NF-kappaB activation, suppressed MTA-induced COX-2 and iNOS mRNA expressions. In addition, MTA increased the production of prostaglandin E(2) in comparison with the controls.
CONCLUSIONS: MTA induces inflammation via NF-kappaB signaling system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482183     DOI: 10.1016/j.joen.2009.03.008

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  7 in total

1.  Reparative dentinogenesis induced by mineral trioxide aggregate: a review from the biological and physicochemical points of view.

Authors:  Takashi Okiji; Kunihiko Yoshiba
Journal:  Int J Dent       Date:  2009-12-28

2.  Histologic tissue response to furcation perforation repair using mineral trioxide aggregate or dental pulp stem cells loaded onto treated dentin matrix or tricalcium phosphate.

Authors:  H Bakhtiar; H Mirzaei; M R Bagheri; N Fani; F Mashhadiabbas; M Baghaban Eslaminejad; D Sharifi; M H Nekoofar; Pmh Dummer
Journal:  Clin Oral Investig       Date:  2016-10-20       Impact factor: 3.573

3.  IFN-γ regulates human dental pulp stem cells behavior via NF-κB and MAPK signaling.

Authors:  Xinyao He; Wenkai Jiang; Zhirong Luo; Tiejun Qu; Zhihua Wang; Ningning Liu; Yaqing Zhang; Paul R Cooper; Wenxi He
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

4.  AP2a enhanced the osteogenic differentiation of mesenchymal stem cells by inhibiting the formation of YAP/RUNX2 complex and BARX1 transcription.

Authors:  Xiao Lin; Haoqing Yang; Lijun Wang; Wenzhi Li; Shu Diao; Juan Du; Songlin Wang; Rui Dong; Jun Li; Zhipeng Fan
Journal:  Cell Prolif       Date:  2018-11-15       Impact factor: 6.831

5.  Yunnan Baiyao Conditioned Medium Promotes the Odonto/Osteogenic Capacity of Stem Cells from Apical Papilla via Nuclear Factor Kappa B Signaling Pathway.

Authors:  Xiyao Pang; Yanqiu Wang; Jintao Wu; Zhou Zhou; Tao Xu; Lin Jin; Yan Yu; Zehan Li; Romila Gobin; Changao Xue; Jinhua Yu
Journal:  Biomed Res Int       Date:  2019-04-23       Impact factor: 3.411

6.  Effects of pulpotomy using mineral trioxide aggregate on prostaglandin transporter and receptors in rat molars.

Authors:  Naoto Ohkura; Naoki Edanami; Ryosuke Takeuchi; Aiko Tohma; Mariko Ohkura; Nagako Yoshiba; Kunihiko Yoshiba; Hiroko Ida-Yonemochi; Hayato Ohshima; Takashi Okiji; Yuichiro Noiri
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

7.  Proliferation, odontogenic/osteogenic differentiation, and cytokine production by human stem cells of the apical papilla induced by biomaterials: a comparative study.

Authors:  Eshaghali Saberi; Narges Farhad-Mollashahi; Fereydoon Sargolzaei Aval; Mersad Saberi
Journal:  Clin Cosmet Investig Dent       Date:  2019-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.